SCHEME 1. Regio- a n d Ster eoselective Rin g
Op en in g of Op tica lly Active Styr en e Oxid e by
In d ole
In Br 3-Ca ta lyzed F r ied el-Cr a fts Ad d ition of
In d oles to Ch ir a l Ar om a tic Ep oxid es: A
F a cile Rou te to En a n tiop u r e In d olyl
Der iva tives
Marco Bandini, Pier Giorgio Cozzi,*
Paolo Melchiorre, and Achille Umani-Ronchi*
Dipartimento di Chimica “G. Ciamician”, Via Selmi 2,
40126 Bologna, Italy
catalytic or stoichiometric amount of Lewis acids.8 Re-
cently, however, an interesting preparation of optically
active compounds bearing aromatic systems was reported
in the literature.9 Focusing on indole-type frameworks,
an elegant catalytic asymmetric Lewis acid mediated
F-C protocol was introduced by J ørgensen et al.10
However, the F-C reaction is particularly critical with
indoles. In fact, their tendency to react with carbonyls
producing diindolyl compounds,11 significantly limited
their use in catalytic strategies. On the other hand, indole
can be added to optically active aromatic epoxides.12
Aromatic epoxides are an ideal source for diversity,
because they can be easily opened with nucleophiles13
furnishing functionally diverse compounds. However, in
the Friedel-Crafts reaction conditions, aromatic optically
active epoxides could rearrange to isomeric carbonyl
compounds or racemize.14 Herein, we report on a straight-
forward InBr3-catalyzed approach toward the preparation
of optically active indolyl derivatives in good yield and
high enantioselectivity (ee up to 99%, Scheme 1).
pgcozzi@ciam.unibo.it; umani@ciam.unibo.it
Received February 18, 2002
Abstr a ct: Aromatic optically active epoxides can be opened
in a regioselective and clean way with indoles in the presence
of catalytic amount of InBr3 (1 mol %). The reaction takes
place with a SN2 pathway affording the 2-aryl-2-(3′-indolyl)-
ethan-1-ols with excellent enantioselectivity (ee up to 99%).
The preparation of enantiopure chiral compounds for
searching biologically active molecules is becoming an
important issue for pharmaceutical industries.1 Diver-
sity,2 exploited in synthesizing arrays of compounds and
coupled with highthroughput screening methodologies,3
is helping for the fast discovery of new active compounds.
In this context, simply synthetic methodologies focused
toward the preparation of chiral optically active com-
pounds can be beneficial to the discovery of new leads.4
Indole is a key motif in many pharmacologically and
biologically active compounds5 as well as in many natural
products it belongs to the class of the alkaloids6 and a
direct synthesis of optically active indolyl derivatives is
desired. Normally, Friedel-Crafts (F-C) reactions7 are
performed in a non-enantioselective way, via the use of
Procedures for the indole ring-opening reaction of
aromatic epoxides are reported in the literature and can
be catalyzed by high pressure (10 kbar) or by the use of
SiO2.12 While the employment of high pressure requires
the use of special equipment, for the latter method,
although simple, several days were necessary in order
(6) (a) The Alkaloids; Specialist Periodical Reports; The Chemical
Society: London, 1971. (b) Saxton, J . E. Nat. Prod. Rep. 1989, 6, 1. (c)
Hesse, M. Alkaloid Chemistry; Wiley: New York, 1978. (d) Cordell, G.
A. Introduction to Alkaloids: A Biogenetic Approach; Wiley: New York,
1981. (e) Gilchrist, T. L. Heterocyclic Chemistry; Pitman: London, 1981.
(f) Pindur, A. R. J . Heterocycl. Chem. 1988, 25, 1. (g) Rainier, J . D.;
Smith, A. B., III. Tetrahedron Lett. 2000, 41, 9419. (h) Bennasar, M.-
L.; Vidal, B.; Bosch, J . J . Org. Chem. 1997, 62, 3597. (i) Amat, M.;
Hadida, S.; Pshenichnyi, G.; Bosch, J . J . Org. Chem. 1997, 62, 3158.
(7) Smith, M. B. Organic Syntheses; McGraw-Hill: New York, 1994;
p 1313.
(8) Olah, G. A.; Khrisnamurti, R.; Surya Prakash, G. K. Compre-
hensive Organic Synthesis, 1st ed.; Pergamon: New York, 1991; Vol.
3, p 293.
(9) Ishii, A.; Soloshonok, V. A.; Mikami, K. J . Org. Chem. 2000, 65,
1597 and references therein.
(10) (a) Gathergood, N.; Zhuang, W.; J ørgensen, K. A. J . Am. Chem.
Soc. 2000, 122, 12517. (b) J ensen K. B.; Thorhauge, J .; Hazel, R. G.;
J ørgensen, K. A. Angew. Chem., Int. Ed. 2001, 40, 160.
(11) (a) Yadav, J . S.; Subba Reddy, B. V.; Murthy, C. V. S. R.;
Mahesh Kumar, G.; Madan, C. Synthesis 2001, 783. (b) Hao, J .;
Taktak, S.; Aikawa, K.; Yusa, Y.; Hatano, M.; Mikami, K. Synlett 2001,
1443.
(12) (a) Kotsuki, H.; Hayashida, K.; Shimanouchi, T.; Nishizawa,
H. J . Org. Chem. 1996, 61, 984. (b) Kotsuki, H.; Nishiuchi, M.;
Kobayashi, S.; Nishizawa, H. J . Org. Chem. 1990, 55, 2969.
(13) (13) (a) Ready, J . M.; J acobsen E. N. J . Am. Chem. Soc. 2001,
123, 2687. (b) Ready, J . M.; J acobsen E. N. J . Am. Chem. Soc. 1999,
121, 6086. (c) Allen A. A.; J acobsen E. N. J . Am. Chem. Soc. 1999,
121, 4147. (d) Hansen, K. B.; Leighton, J . L.; J acobsen E. N. J . Am.
Chem. Soc. 1996, 118, 10924.
* To whom correspondence should be addressed. Tel: +39-051-
2099509. Fax: +39-2099456.
(1) Chem. Eng. News 2001, 28, 79.
(2) (a) Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Angew. Chem., Int.
Ed. 2001, 40, 2004. (b) Brown, R. C. D. J . Chem. Soc., Perkin Trans
1988, 3293. (c) Blackbourn, C.; Albericio, F.; Kates, S. A. Drugs future
1997, 22, 1007. (d) Fruchtel, J . S.; J ung, G. Angew. Chem., Int. Ed.
Engl. 1996, 35, 17. (e) Balkenhohl, F.; Von dem Bussche-Hunnefeld,
C.; Lansky, A.; Zechel, C. Angew. Chem., Int. Ed. Engl. 1996, 35, 2288.
(f) Hermkens, P. H.; Ottenheijm, H. C. J .; Rees, D. Tetrahedron 1996,
52, 4527.
(3) Fenniri, H. Combinatorial Chemistry; Oxford University Press:
Oxford, 2000.
(4) (a) Smith, A. L.; Stevenson, G. I.; Lewis, S.; Patel, S.; Castro, J .
L. Biorg. Med. Chem. Lett. 2000, 10, 2693. (b) Liu, Y.; Gribble, G. W.
Tetrahedron Lett. 2000, 41, 8717. (c) Spadoni, G.; Balsamini, C.; Bedini,
A.; Diamantini, G.; Di Giacomo, B.; Tontini, A.; Tarzia, G.; Mor, M.;
Plazzi, P. V.; Rivara, S.; Nonno, R.; Pannacci, M.; Lucini, V.; Fraschini,
F.; Stankov, B. M. J . Med. Chem. 1998, 41, 3624. (d) Andersen, K.;
Liljefors, T.; Hyttel, J .; Perregaard, J . J . Med. Chem. 1996, 39, 3723.
(e) Srges, R.; Howard, H. R.; Koe, B. K.; Weissman, A. J . Med. Chem.
1989, 32, 3723.
(5) (a) Glennon, R. A. J . Med. Chem. 1997, 40, 1. J ung, M. E.;
Slowinski, F. Tetrahedron Lett. 2001, 42, 6835. (b) Walsh, T.; Toupence,
R. B.; Ujjainwalla, F.; Young, J . R.; Goulet, M. T. Tetrahedron 2001,
57, 5233. (c) Russell, M. G. N.; Baker, R. J .; Barden, L.; Beer, M. S.;
Bristow, L.; Howard, H. B.; Broughton, B.; Knowles, M.; McAllister,
G.; Patel, S.; Castro, J . L. J . Med. Chem. 2001, 44, 3881. (d) Zhang,
H.-C.; Ye, H.; Moretto, A. F.; Brumfield, K. K.; Maryanoff, B. E. Org.
Lett. 2000, 2, 89.
(14) Ranu, B. C.; J ana, U. J . Org. Chem. 1998, 63, 8212.
10.1021/jo0256235 CCC: $22.00 © 2002 American Chemical Society
Published on Web 06/18/2002
5386
J . Org. Chem. 2002, 67, 5386-5389